[go: up one dir, main page]

WO2003082819A1 - N-phenyl-n-(4-piperidinyl)amide derivative - Google Patents

N-phenyl-n-(4-piperidinyl)amide derivative Download PDF

Info

Publication number
WO2003082819A1
WO2003082819A1 PCT/JP2003/003948 JP0303948W WO03082819A1 WO 2003082819 A1 WO2003082819 A1 WO 2003082819A1 JP 0303948 W JP0303948 W JP 0303948W WO 03082819 A1 WO03082819 A1 WO 03082819A1
Authority
WO
WIPO (PCT)
Prior art keywords
phenyl
piperidinyl
amide derivative
derivative
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2003/003948
Other languages
French (fr)
Japanese (ja)
Inventor
Toshihiro Takahashi
Kunio Kobayashi
Shinichi Yoshida
Tsuyoshi Endo
Nobutaka Mochiduki
Tomio Yamakawa
Kiichi Shika
Toru Kawasaki
Kenji Hirate
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Priority to JP2003580287A priority Critical patent/JPWO2003082819A1/en
Priority to AU2003220898A priority patent/AU2003220898A1/en
Publication of WO2003082819A1 publication Critical patent/WO2003082819A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An N-phenyl-N-(4-piperidinyl)amide derivative represented by the following general formula (I): (I) (wherein R1 represents C1-6 alkyl, etc.; R2 and R4 each represents optionally substituted phenyl; R3 represents hydrogen, C2-8 alkoxycarbonyl, or methyl substituted by C1-6 alkoxy; R5 represents a residue of an amino acid such as glycine, alanine, leucine, or phenylalanine; and m is 1 or 2) or a salt of the derivative; and a peripheral analgesic containing the derivative or salt as an active ingredient.
PCT/JP2003/003948 2002-04-01 2003-03-28 N-phenyl-n-(4-piperidinyl)amide derivative Ceased WO2003082819A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2003580287A JPWO2003082819A1 (en) 2002-04-01 2003-03-28 N-phenyl-N- (4-piperidinyl) amide derivatives
AU2003220898A AU2003220898A1 (en) 2002-04-01 2003-03-28 N-phenyl-n-(4-piperidinyl)amide derivative

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002-098443 2002-04-01
JP2002098443 2002-04-01

Publications (1)

Publication Number Publication Date
WO2003082819A1 true WO2003082819A1 (en) 2003-10-09

Family

ID=28671952

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2003/003948 Ceased WO2003082819A1 (en) 2002-04-01 2003-03-28 N-phenyl-n-(4-piperidinyl)amide derivative

Country Status (3)

Country Link
JP (1) JPWO2003082819A1 (en)
AU (1) AU2003220898A1 (en)
WO (1) WO2003082819A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004046107A1 (en) * 2002-11-19 2004-06-03 Takeda Pharmaceutical Company Limited Indole derivatives as somatostatin agonists or antagonists
WO2005030722A1 (en) * 2003-09-29 2005-04-07 Nippon Chemiphar Co., Ltd. N-substituted-n-(4-piperidinyl) amide derivative
WO2006030931A1 (en) * 2004-09-14 2006-03-23 Nippon Chemiphar Co., Ltd. N-substituted n-(4-piperidinyl)amide derivative
JP2008511576A (en) * 2004-08-31 2008-04-17 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド Stabilization of organic materials
US10766925B2 (en) * 2016-04-11 2020-09-08 Arizona Board Of Regents On Behalf Of The University Of Arizona Opioid receptor modulators

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995028931A1 (en) * 1994-04-26 1995-11-02 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
JPH08337569A (en) * 1995-06-15 1996-12-24 Sankyo Co Ltd Analgesic active substance
WO1999045011A1 (en) * 1998-03-06 1999-09-10 Janssen Pharmaceutica N.V. Glycine transport inhibitors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995028931A1 (en) * 1994-04-26 1995-11-02 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
JPH08337569A (en) * 1995-06-15 1996-12-24 Sankyo Co Ltd Analgesic active substance
WO1999045011A1 (en) * 1998-03-06 1999-09-10 Janssen Pharmaceutica N.V. Glycine transport inhibitors

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004046107A1 (en) * 2002-11-19 2004-06-03 Takeda Pharmaceutical Company Limited Indole derivatives as somatostatin agonists or antagonists
WO2005030722A1 (en) * 2003-09-29 2005-04-07 Nippon Chemiphar Co., Ltd. N-substituted-n-(4-piperidinyl) amide derivative
JP2008511576A (en) * 2004-08-31 2008-04-17 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド Stabilization of organic materials
US9051448B2 (en) 2004-08-31 2015-06-09 Basf Se Stabilization of organic materials
WO2006030931A1 (en) * 2004-09-14 2006-03-23 Nippon Chemiphar Co., Ltd. N-substituted n-(4-piperidinyl)amide derivative
US10766925B2 (en) * 2016-04-11 2020-09-08 Arizona Board Of Regents On Behalf Of The University Of Arizona Opioid receptor modulators

Also Published As

Publication number Publication date
AU2003220898A1 (en) 2003-10-13
JPWO2003082819A1 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
WO2003076458A3 (en) Selective dipeptide inhibitors of kallikrein
EP1674452A4 (en) Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor
IL147651A0 (en) Isoxazoline derivative and herbicide containing the same as the active ingredient
AU2003246100A1 (en) Amide derivative
CA2424600A1 (en) Aliphatic nitrogenous five-membered ring compounds
AU2003275826A1 (en) Macrocyclic peptides active against the hepatitis c virus
MY127791A (en) Hepatitis c inhibitor tri-peptides
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
FI950309A0 (en) proline amide derivative
WO2003064455A3 (en) Macrocyclic peptides active against the hepatitis c virus
NZ536734A (en) Spiroindolinepiperidine derivatives
WO2007056517A3 (en) Pharmaceutical salts and polymorphs of n- (5-chl0r0-2-pyridinyl) -2- [ [4- [ (dimethylamino) iminomethyl] benzoyl] amino] -5-meth oxy-benzamide, a factor xa inhibitor
ATE374765T1 (en) SUBSTITUTED HETEROCYCLIC AMIDES
DK1008592T3 (en) Cyclic amide derivatives which inhibit cathepsin K
MXPA06003253A (en) ((((1h-indol-3yl) methylidene)amino)oxy)acetic acid derivatives and related compounds as pai-1 inhibitors for the treatment of inpairement of the fibrinolytic system and of thrombosis.
DK0615978T3 (en) Peptide derivatives of boric acid having protease inhibitory effect, method of preparation thereof and pharmaceutical compositions
WO2003064429A1 (en) Thienopyrimidines, process for preparing the same and use thereof
EP1295876A4 (en) Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them
EA200400994A1 (en) NEW 1,2,3-SUBSTITUTED INDOLYSINE DERIVATIVES THAT ARE INHIBITORS OF FIBROBLAST GROWTH FACTORS, METHOD OF THEIR RECEIVING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MXPA05013584A (en) Cyclic tertiary amine compound.
EP1553096A4 (en) PYRAZOLE COMPOUNDS
WO2003082819A1 (en) N-phenyl-n-(4-piperidinyl)amide derivative
AU2003241060A1 (en) New atorvastatin salts and pharmaceutical compositions containing them
AR044175A1 (en) CEFEMO COMPOUNDS
ATE373636T1 (en) AMIDE DERIVATIVES AS INHIBITORS OF THE ENZYMATIC ACTIVITY OF RENIN

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003580287

Country of ref document: JP

122 Ep: pct application non-entry in european phase